On day 1 of the Family Heart Global Summit, speakers highlighted the critical need for awareness, early diagnosis, and innovative treatment options for familial hypercholesterolemia, sharing ...
FDA expands Juxtapid approval for pediatric patients aged 2 years and older with homozygous familial hypercholesterolemia to ...
Evkeeza is a first-in-class medicine approved by Health Canada, the U.S. Food and Drug Administration (FDA) and European Commission (EC) to treat an ultrarare, inherited form of high cholesterol ...
Familial hypercholesterolemia is an inherited condition in which a genetic defect causes elevated cholesterol levels from the very first years of life, leading to a heightened risk of heart disease.
DEAR DR. ROACH: I am a 69-year-old woman who was diagnosed with familial hypercholesterolemia (FH). I used statins for over a decade but developed vulvar lichen sclerosus (LS), which only went away ...
The Family Heart Foundation, a leading research and advocacy organization, shared results from an analysis of its large U.S. Family Heart Database TM showing significant disparities exist in the ...
ANAHEIM, Calif.--(BUSINESS WIRE)--The Family Heart Foundation, a leading research and advocacy organization, shared results from an analysis of patients in its CASCADE FH ® Registry showing that ...
Methods In this phase 3, double-blind trial, we randomly assigned, in a 1:1 ratio, 482 adults who had heterozygous familial hypercholesterolemia to receive subcutaneous injections of inclisiran sodium ...
Heterozygous familial hypercholesterolemia (HeFH) is a genetic disorder a person can inherit from a parent. It can cause a person to develop dangerously high cholesterol levels. HeFH affects how a ...
Please provide your email address to receive an email when new articles are posted on . Familial hypercholesterolemia is underdiagnosed and undertreated. A novel machine learning algorithm identified ...
12don MSN
Canadian pediatricians call for cholesterol checks for kids as young as 2 to catch heart risks early
The Canadian Paediatric Society is recommending cholesterol screening for all children between two and 10 years old, saying ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results